Low prevalence of colonoscopic surveillance of inflammatory bowel disease patients with longstanding extensive colitis: a clinical practice survey nested in the CESAME cohort

Aliment Pharmacol Ther 2011; 34: 188–195 Summary Background Surveillance colonoscopy is recommended for inflammatory bowel disease (IBD) patients with longstanding extensive colitis (LEC). Aims To assess modalities and results of colonoscopic surveillance in a subset of CESAME cohort patients at high risk of colorectal cancer (CRC) and followed in university French hospitals. Methods Among 910 eligible patients with more than a 7‐year history of extensive colitis at CESAME enrolment, 685 patients completed a questionnaire on surveillance colonoscopy and 102 were excluded because of prior proctocolectomy. Finally, 583 patients provided information spanning a median period of 41 months (IQR 38‐43) between cohort enrolment and the end of follow‐up. Details of the colonoscopic procedures and histological findings were obtained for 440 colonoscopies in 270 patients. Results Only 54% (n = 312) of the patients with LEC had at least one surveillance colonoscopy during the study period, with marked variations across the nine participating centres (27% to 70%, P ≤ 0.0001). Surveillance rate was significantly lower in Crohn’s colitis than in ulcerative colitis (UC) (48% vs. 69%, P ≤ 0.0001). Independent predictors of colonoscopic surveillance were male gender, UC IBD subtype, longer disease duration, previous history of CRC and disease management in a centre with large IBD population. Random biopsies, targeted biopsies and chromoendoscopy were performed during respectively 71%, 27 and 30% of surveillance colonoscopies. Two cases of high‐grade dysplasia were detected in patients undergoing colonoscopic surveillance. Two advanced‐stage CRC were diagnosed in patients who did not have colonosocopic surveillance. Conclusions Colonoscopic surveillance rate is low in IBD patients with longstanding extensive colitis.